Shichiri M - Search Results

1

GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomics.

Masaki T, Kodera Y, Terasaki M, Fujimoto K, Hirano T, Shichiri M. Masaki T, et al. Among authors: shichiri m. Sci Rep. 2021 Jul 14;11(1):14470. doi: 10.1038/s41598-021-93862-w. Sci Rep. 2021. PMID: 34262109 Free PMC article.

2

Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.

Watanabe T, Suguro T, Sato K, Koyama T, Nagashima M, Kodate S, Hirano T, Adachi M, Shichiri M, Miyazaki A. Watanabe T, et al. Among authors: shichiri m. Hypertens Res. 2008 Mar;31(3):463-8. doi: 10.1291/hypres.31.463. Hypertens Res. 2008. PMID: 18497465

3

Release of salusin-beta from human monocytes/macrophages.

Sato K, Fujimoto K, Koyama T, Shichiri M. Sato K, et al. Among authors: shichiri m. Regul Pept. 2010 Jun 8;162(1-3):68-72. doi: 10.1016/j.regpep.2010.02.010. Epub 2010 Feb 20. Regul Pept. 2010. PMID: 20176058

4

Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.

Nagashima M, Watanabe T, Shiraishi Y, Morita R, Terasaki M, Arita S, Hongo S, Sato K, Shichiri M, Miyazaki A, Hirano T. Nagashima M, et al. Among authors: shichiri m. Atherosclerosis. 2010 Sep;212(1):70-7. doi: 10.1016/j.atherosclerosis.2010.04.027. Epub 2010 May 4. Atherosclerosis. 2010. PMID: 20684826

5

The roles of salusins in atherosclerosis and related cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Iso Y, Nagashima M, Hirano T, Shichiri M. Watanabe T, et al. Among authors: shichiri m. J Am Soc Hypertens. 2011 Sep-Oct;5(5):359-65. doi: 10.1016/j.jash.2011.06.003. J Am Soc Hypertens. 2011. PMID: 21925457 Review.

6

Endogenous bioactive peptides as potential biomarkers for atherosclerotic coronary heart disease.

Watanabe T, Sato K, Itoh F, Wakabayashi K, Shichiri M, Hirano T. Watanabe T, et al. Among authors: shichiri m. Sensors (Basel). 2012;12(4):4974-85. doi: 10.3390/s120404974. Epub 2012 Apr 18. Sensors (Basel). 2012. PMID: 22666071 Free PMC article. Review.

7

Serum monomeric α2-macroglobulin as a clinical biomarker in diabetes.

Takada T, Kodera Y, Matsubara M, Kawashima Y, Maeda T, Fujita Y, Shichiri M. Takada T, et al. Among authors: shichiri m. Atherosclerosis. 2013 May;228(1):270-6. doi: 10.1016/j.atherosclerosis.2013.02.035. Epub 2013 Mar 13. Atherosclerosis. 2013. PMID: 23535567

8

Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Noguchi Y, Fujimoto K, Koyama T, Shichiri M. Watanabe T, et al. Among authors: shichiri m. Curr Protein Pept Sci. 2013 Sep;14(6):472-80. doi: 10.2174/13892037113149990064. Curr Protein Pept Sci. 2013. PMID: 23968353 Review.

9

Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.

Fujimoto K, Hayashi A, Kamata Y, Ogawa A, Watanabe T, Ichikawa R, Iso Y, Koba S, Kobayashi Y, Koyama T, Shichiri M. Fujimoto K, et al. Among authors: shichiri m. PLoS One. 2013 Oct 3;8(10):e76714. doi: 10.1371/journal.pone.0076714. eCollection 2013. PLoS One. 2013. PMID: 24098553 Free PMC article.

10

Physiological fluctuations of human plasma total salusin-β, an endogenous parasympathomimetic/proatherosclerotic peptide.

Ogawa A, Fujimoto K, Hayashi A, Chida S, Sato K, Takai K, Masaki T, Suzuki A, Kamata Y, Takano K, Koyama T, Shichiri M. Ogawa A, et al. Among authors: shichiri m. Peptides. 2014 Sep;59:83-8. doi: 10.1016/j.peptides.2014.07.009. Epub 2014 Jul 22. Peptides. 2014. PMID: 25063054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters